ICER Can Do Better for Patients.
J Manag Care Spec Pharm
; 25(5): 514-516, 2019 May.
Article
en En
| MEDLINE
| ID: mdl-31039068
DISCLOSURES: No outside funding supported the writing of this article. Mendez is president and CEO of the Asthma and Allergy Foundation of America, which receives greater than 25% of its funding to produce educational materials and for patient research through grants from pharmaceutical companies, including AstraZeneca, Genentech, GSK, Sanofi/Regeneron, and Teva.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
1_financiamento_saude
/
6_asthma
/
6_other_respiratory_diseases
Asunto principal:
Asma
/
Interpretación Estadística de Datos
/
Análisis Costo-Beneficio
/
Modelos Económicos
/
Antiasmáticos
Tipo de estudio:
Health_economic_evaluation
/
Prognostic_studies
Aspecto:
Patient_preference
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Manag Care Spec Pharm
Año:
2019
Tipo del documento:
Article
